(Q62105918)
Statements
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine Safety and Pharmacokinetics of Exenatide Long-Acting Release Administered Weekly in Subjects With Type 2 Diabetes Mellitus (English)
0 references
February 2005
0 references
October 2005
0 references
45
0 references